Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GLP-1 agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice
Meltem Dönmez Kutlu, Seda Köse, Kübra Akıllıoğlu
Behavioural Brain Research (2023) Vol. 445, pp. 114386-114386
Closed Access | Times Cited: 16

Showing 16 citing articles:

GLP-1 programs the neurovascular landscape
Bandy Chen, Xiaofei Yu, Claudia Horvath-Diano, et al.
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2173-2189
Closed Access | Times Cited: 10
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access | Times Cited: 1
The potential role of Tirzepatide as adjuvant therapy in countering colistin-induced nephro and neurotoxicity in rats via modulation of PI3K/p-Akt/GSK3-β/NF-kB p65 hub, shielding against oxidative and endoplasmic reticulum stress, and activation of p-CREB/BDNF/TrkB cascade
Noha F. Hassan, Diaa Ragab, Shaimaa G. Ibrahim, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112308-112308
Closed Access | Times Cited: 8
The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review
Silvia Tempia Valenta, Alba Nicastri, Federica Perazza, et al.
Current Treatment Options in Psychiatry (2024)
Closed Access | Times Cited: 6
Ononin ameliorates depression-like behaviors by regulating BDNF-TrkB-CREB signaling in vitro and in vivo
Guowei Gong, Kumar Ganesan, Yongjie Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 320, pp. 117375-117375
Closed Access | Times Cited: 12
The effect of caffeine in a model of schizophrenia-like behavior induced by MK-801 in mice
Kübra Akıllıoğlu, Seda Köse Korkmaz, Meltem Dönmez Kutlu
Behavioural Brain Research (2025), pp. 115468-115468
Closed Access
Therapeutic Targets and Molecular Mechanisms of Calycosin in the Treatment of Depression: Insights From Chronic Mild Stress Animal Models
Guowei Gong, Yaqun Liu, Zhenxia Zhang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 4
Open Access
Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction with Neurodegenerative Diseases
Moeka Nakashima, Naoko Suga, Sayuri Yoshikawa, et al.
(2024)
Open Access | Times Cited: 3
Impact of Glucagon-like Peptide-1 Receptor Agonists on Mental Illness: Evidence from a Mendelian Randomization Study
Xiang Lin, Ying Peng
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2741-2741
Open Access
Exploring the Connection Between BDNF/TrkB and AC/cAMP/PKA/CREB Signaling Pathways: Potential for Neuroprotection and Therapeutic Targets for Neurological Disorders
Abhishek Gupta, Sumedha Gupta, Sidharth Mehan, et al.
Molecular Neurobiology (2025)
Closed Access
Low-dose lithium mono- and adjunctive therapies improve MK-801-induced cognitive impairment and schizophrenia-like behavior in mice - Evidence from altered prefrontal lobe Ca2+ activity
Chuanjun Zhuo, Hongjun Tian, Guangdong Chen, et al.
Journal of Affective Disorders (2023) Vol. 337, pp. 128-142
Closed Access | Times Cited: 4
Liraglutide attenuates palmitate-induced apoptosis via PKA/β-catenin/Bcl-2/Bax pathway in MC3T3-E1 cells
Lanlan Cheng, Yijing Xu, Yueming Long, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 1, pp. 329-341
Open Access | Times Cited: 3
Effect of D‐pinitol on MK‐801‐induced schizophrenia‐like behaviors in mice
Jae Youn Kim, Chang Hyeon Kong, Do Yeon Kim, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5904-5915
Closed Access | Times Cited: 3
Safety of current treatment options for NTRK fusion-positive cancers
Adeline Yang, Theodore W. Laetsch
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 11, pp. 1073-1089
Closed Access | Times Cited: 3
Adjunctive clozapine with bright light mitigates cognitive deficits by synaptic plasticity and neurogenesis in sub-chronic MK-801 treated mice
Lizhi Zhang, Yiying Zhou, Yanhong Xie, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 243, pp. 173821-173821
Closed Access
Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases
Moeka Nakashima, Naoko Suga, Sayuri Yoshikawa, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3922-3922
Open Access
CREB: A Promising Therapeutic Target for Treating Psychiatric Disorders
Wei Guan, Ni Meixin, Haijuan Gu, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 14, pp. 2384-2401
Closed Access
Page 1

Scroll to top